Back to YC Companies
Actipulse Neuroscience
Winter 2022
Active
Bringing non-invasive brain stimulation from the hospital to the home
38 people View on YC
Actipulse Neuroscience at a glance
- Y Combinator batch
- Winter 2022
- Status
- Active
- Industry
- Healthcare
- Team size
- 38 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Actipulse Neuroscience
Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.
Tags:
Mental Health Tech
Neurotechnology
Medical Devices